Skip to main content
Premium Trial:

Request an Annual Quote

Consumer Genomics Startup Navigenics Makes Official Debut; Names Sue Siegel as Director

NEW YORK (GenomeWeb News) — Navigenics, a Bay Area company focused on using whole-genome scanning to identify an individuals’ genetic risks for certain diseases, today said it has made its official debut as a company.
 
The firm said it has also secured a Series B round of venture capital financing for an undisclosed amount, bringing its total funding to $25 million to date.
 
The company, which has named as a director former Affymetrix President Sue Siegel, said it will initially use saliva-based tests and genome scans to “help people understand their genetic predisposition to disease and arm them with the information about what actions to take.” Siegel is a partner with MDV-Mohr Davidow Ventures, which participated in the round.
 
Beside MDV-Mohr Davidow Ventures, Navigenics said participants in the financing included Kleiner Perkins Caufield & Byers and Sequoia Capital.

The Scan

Bit of Each

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.